Fundación Neumologica Colombiana Report issue

Foundation

Organization Overview

First Clinical Trial
2016
NCT03020212
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Fundación Neumologica Colombiana | Fundación Neumológica Colombiana

Active Ingredients

Drugs in Other Trials (2)

oxygen (1 trial)

wharton's jelly mesenchymal stem cells (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2